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diabetic patients was 62.8-86.3% and for patients with CVD was 38.8-60.0%. 
Forgetfulness, lack of knowledge about medical condition and prescribed 
medications, and concerns about medications were consistently reported as 
barriers to AM. Patient education plus telephone or short message service follow-
ups improved AM in diabetic patients. We found no high quality trials on AM 
improving interventions for patients with CVD. CONCLUSIONS: Non-adherence 
to medications may not be assured for accessible medicines in resource-limited 
settings. We strongly suggest for multidisciplinary policies and interventions on 
patient education and reinforcement strategies to address the issue of non-
adherence to medications.  
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OBJECTIVES: Much research exists on medication adherence, however, clear 
evidence is lacking on specific methods to achieve lower rates of non-
compliance. The purpose of this study was to evaluate the differences in 
cholesterol medication adherence at primary care practices who have 
implemented a patient centered medical home (PCMH) as compared to usual 
primary care (UPC). METHODS: A retrospective cohort study analyzed medical 
and pharmacy claims from continuously enrolled Medicare Part D members at 
least 18 years old at UPMC Health Plan. We compared PCMH and USP practices 
over a one year period (2011) for medication adherence of statin drugs. 
Standardized metrics from the Medicare Health and Drug Plan Quality and 
Performance Ratings 2012 were used. Exclusion criteria were as follows: switched 
between PCMH/UPC practice in 2011; pharmacist on-site at practice; PCMH 
implemented for <6 months at practice. Members who had at least 2 fills in the 
same drug class during the period were included. RESULTS: A total of 1,227 
members in 21 PCMH practices were compared to 17,599 members in 1,283 UPC 
practices. Chi-square tests showed no difference in age, sex or disease burden 
(using Charleson Comorbidity Index) between the groups. There was a 
significant increase in the percentage of members with a medication possession 
ratio (MPR) of at least 80% for cholesterol medications (75.7% in PCMH vs.72.9% in 
UPC), p=0.03. CONCLUSIONS: This research informs investment in the PCMH 
model which may have an unreported value stream related to medication 
adherence. The increase in percentage of members with MPR>=80% in the PCMH 
group translates to increased CMS star rating of 5. The 5 Star threshold is 75.4%. 
This is of benefit to the insurer towards the contribution of the overall CMS Star 
Rating of the Medicare plan, as this metric is weighted three times more than 
most measures.  
 
PCV112  
UTILITY EVALUATION OF HEALTH STATES RELATED TO STROKE AND STROKE 
PROPHYLAXIS  
Wang Y1, Kong MC2, Ko Y1 
1National University of Singapore, Singapore, Singapore, 2Singapore General Hospital, Singapore, 
Singapore, Singapore  
OBJECTIVES: In addition to warfarin, the drugs dabigatran and rivaroxaban have 
been used to prevent strokes in patients with atrial fibrillation. However, their 
impact on patients’ health-related quality of life remains unknown. This study 
aimed to use the visual analogue scale (VAS) and standard gamble (SG) to elicit 
patient-reported utilities for health states related to stroke and stroke 
prophylaxis by the three anticoagulants. METHODS: A cross-sectional survey 
was administered in 2012 to a convenience sample of 100 patients taking 
warfarin in an anticoagulation clinic. The survey questionnaire included socio-
demographics, clinical characteristics, and questions to elicit utilities for seven 
chronic and four temporary health states. Participants completed the 
questionnaire in English or Chinese, depending on their preference. Logical 
consistency and correlations between the VAS and SG were assessed. RESULTS: 
When the SG was used, the three health states with the highest mean utilities 
were “well on rivaroxaban” (0.90), “current health state” (0.86) and “well on 
warfarin” (0.86). The three health states with the lowest mean utilities were 
intracranial bleeding (ICH) (-0.09), major ischemic stroke (IS) (-0.01) and 
myocardial infarction (0.45). Logical consistency was found: 1) the mean utilities 
of “well on warfarin”, “well on dabigatran”, “well on rivaroxaban” and “current 
health state” were higher than those of other chronic health states (all p<0.001); 
2) the mean utilities of major IS and ICH were lower than those of minor IS and 
transient ischemic attack (all p<0.001); and 3) the mean utility of major 
extracranial hemorrhage (ECH) was lower than that of minor ECH (all p<0.001). 
Significant correlations were found between the two measures (all p<0.05). 
CONCLUSIONS: The elicited utilities of the anticoagulants were, in a decreasing 
order: rivaroxaban, warfarin and dabigatran. The results of this study can be 
used in future cost-utility analysis.  
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OBJECTIVES: Traditional Chinese Medicine Syndrome Angina Questionnaire 
(TCMSAQ) was a well-developed disease and syndrome combined questionnaire. 
The syndromes domains were alternated when evaluating the corresponding 
syndromes. In this research, we offered a new view for scale development and 
applications—Disease Generic Module (DGM) and Syndrome Specific Module 
(SSM). Thus, the aim was to reset the TCMSAQ, evaluate the TCMSAQ-DGM’s 
psychometrics, and apply it. METHODS: The data resources came from a cross-
sectional clinical survey of angina patients in 12 centered hospitals. All the 
participants filled in the TCMSAQ-DGM with 5 domains (without syndrome) and 
22 items. Seattle Angina Questionnaire (SAQ) and SF-12 were administered to 
assess criterion validity. The reliability was evaluated on the basis of internal 
consistency, test-retest reliability. Construction validity was tested by 
exploratory factor analysis (EFA). Discriminate validity was assessed by detecting 
differences from known groups with different Canadian Cardiovascular Society 
Classification (CCSC) levels and Body Mass Index (BMI). RESULTS: A total of 1756 
(98.21%) patients (PBS, 785; QBS, 777; age 59±10 years; 905 male, 52%) participated 
the research. TCMSAQ-DGM Cronbach’s alpha coefficient was 0.822; Test-retest 
correlation coefficient (CC) was 0.946 (P=0.00). EFA showed 7 factors matching 
the expected conceptual framework. Criterion validity demonstrated that 
TCMSAQ-DGM related with SAQ similar domains (CC, 0.108~0.771; P=0.00). The 
mean scores of the TCMSAQ-DGM in patients with CCSC ±to ‡W were 74.58, 
72.26, 67.56, 55.25 (P=0.00) and also can TCMSAQ-DGM distinguish patients in 
activity limitations and worry domains with different CCSC levels. However, the 
Body Mass Index (BMI>25 indicated overweight) manifested that overweight 
patients were more worried about the death of angina. Considering two different 
syndromes, TCMSAQ-DGM only showed PBS patients’ sleep better than QBS 
individuals’. CONCLUSIONS: The reset TCMSAQ-DGM has good psychometric 
properties, and can be applied in TCM clinical practice. Further researches of 
DGM and SSM’s relationship and applications will be discussed.  
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OBJECTIVES: To assess the reliability of the quality of life instrument used in the 
COURAGE trial. METHODS: We used data from the COURAGE study, a 
randomized trial evaluating the outcomes of optimal medical therapy (OMT) 
with or without percutaneous coronary intervention (PCI). A total of 2,287 
patients with stable Coronary disease were enrolled and followed for a median of 
4.6 years. Angina-specific health status was assessed with the Seattle Angina 
Questionnaire (SAQ) at baseline and at 1, 3, 6 and 12 months followed by annual 
evaluations. The SAQ consists of five domains: the physical limitation, angina 
stability, angina frequency, treatment satisfaction, and quality of life. Scores in 
each domain range from 0 to 100, with higher scores indicating better health 
status. Cronbach’s alpha was used to estimate the reliability of each domain in 
SAQ. RESULTS: At baseline, the correlation coefficients between the domain of 
physical limitation, angina frequency, or quality of life and the composite score 
of all five domains were 0.54, 0.63, and 0.65, respectively; but the coefficients 
between the angina stability or treatment satisfaction and the composite score 
were 0.49, and 0.27, respectively. If the domain of physical limitation, angina 
frequency, or quality of life is deleted, Cronbach’s alpha will decrease from 0.75 
to 0.69, 0.66, or 0.64, respectively; however, if the angina stability is deleted, 
Cronbach’s alpha will change from 0.75 to 0.72, and if the treatment satisfaction 
is deleted, Cronbach’s alpha will increase from 0.75 to 0.78. Similar results can be 
seen over the follow-up time. CONCLUSIONS: The angina stability and treatment 
satisfaction domains should be excluded since they had weak relationship with 
the entire SAQ instrument. Three domains of the physical limitation, angina 
frequency, and quality of life thoroughly reflected the impact of angina on a 
patient’s health status and disease related quality of life.  
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OBJECTIVES: It is well documented that antithrombotic therapies prevent 
thrombotic events (benefits) in many clinical settings, but also are associated 
with an increased risk of bleeding (risks). However, it is not entirely clear how 
the tradeoff between these health outcomes is perceived by patients and 
physicians, particularly when treating acute coronary syndrome (ACS). The 
current study aims to quantify US patient and physician preferences for health 
outcomes associated with antithrombotic therapies in ACS. METHODS: Patients 
≥18 years old who were hospitalized within the last 5 years due to a heart attack 
and have used aspirin or prescription blood thinners, and board-certified 
cardiologists participated in a web-based, best-worst scaling survey. Each best-
worst scaling question included 3 possible outcomes and participants were 
asked to select the best and worst outcomes in each question. Outcomes 
included death, and various levels of stroke, myocardial infarction, and bleeding. 
Data were analyzed using a maximum difference model employing random-
parameters logit. RESULTS: Responses from 206 patients and 273 physicians met 
face validity requirements and were analyzed. For both physicians and patients, 
non-fatal major disabling stroke was nearly equivalent to death in terms of 
relative importance, and non-fatal moderate bleeding was the least important. 
For physicians, severe myocardial infarction was equivalent to 0.92 (standard 
error, ±0.02) deaths, while non-fatal moderate stroke was equivalent to 0.64 
(±0.05) deaths. For patients, non-fatal moderate stroke was equivalent to 0.35 
(±0.04) deaths, while non-fatal major bleeding requiring transfusion was 
equivalent to 0.13 (±0.02) deaths, and non-fatal heart attack was equivalent to 
0.09 (±0.02) deaths. All remaining ACS outcomes were equivalent to fewer than 
0.03 deaths. CONCLUSIONS: US patients and physicians viewed death and 
disabling stroke as the most important and non-fatal moderate bleeding as the 
